Search results for "Irritable bowel syndrome"
AGA issues best practice advice on IBS and diet
Dietary advice is ideally prescribed to patients with irritable bowel syndrome (IBS) who have insight into their meal-related GI symptoms and are motivated to make changes, the American Gastroenterological Association (AGA) said.
https://gastroenterology.acponline.org/archives/2022/04/22/2.htm
22 Apr 2022
MKSAP Quiz: Watery, nonbloody diarrhea and abdominal pain
This month's quiz asks readers to determine the most appropriate diagnostic test to perform in a 25-year-old patient with watery, nonbloody diarrhea of 9 months' duration, usually accompanied by abdominal pain in the periumbilical area or left lower quadrant.
https://gastroenterology.acponline.org/archives/2022/04/22/4.htm
22 Apr 2022
AGA issues guidance on drug treatment for patients with IBS
Two new clinical practice guidelines from the American Gastroenterological Association (AGA) provide recommendations on the use of medications to treat irritable bowel syndrome (IBS) with constipation and IBS with diarrhea.
https://gastroenterology.acponline.org/archives/2022/06/24/1.htm
24 Jun 2022
Spotlight on long-term effects of FMT
Recent studies found evidence of long-term safety and efficacy of fecal microbiota transplantation (FMT) for irritable bowel syndrome and other GI diseases.
https://gastroenterology.acponline.org/archives/2022/06/24/5.htm
24 Jun 2022
In drug-refractory IBS, group CBT with interoceptive exposure improved symptoms and quality of life at 13 wk
Given the results of this small, randomized trial, a head-to-head comparison of multidisciplinary care versus group cognitive behavioral therapy (CBT) delivered over the internet for patients with irritable bowel syndrome (IBS) is now warranted, an ACP Journal Club commentary noted.
https://gastroenterology.acponline.org/archives/2022/08/26/10.htm
26 Aug 2022
In IBS, a smartphone application for self-managing a FODMAP-lowering diet vs. otilonium bromide reduced symptoms at 8 wk
Delivery of a fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP)-lowering dietary intervention via an app may help educate patients about diet and augment the clinician-patient relationship, an ACP Journal Club commentary noted.
https://gastroenterology.acponline.org/archives/2022/08/26/9.htm
26 Aug 2022
Recommendations for pharmacologic management of IBS with diarrhea, constipation
New guidelines suggest that there are several effective drugs available for irritable bowel syndrome (IBS), but a more detailed analysis indicates that the best treatments increase the rate of response by only 15% versus placebo, an ACP Journal Club commentary said.
https://gastroenterology.acponline.org/archives/2022/11/18/8.htm
18 Nov 2022
Response to linaclotide for IBS constipation can still appear after four weeks
An industry-funded analysis of four randomized trials of linaclotide for irritable bowel syndrome (IBS) with constipation found that improvement in abdominal and bowel symptoms occurred after four weeks of treatment in 1 in 6 and 1 in 10 patients, respectively.
https://gastroenterology.acponline.org/archives/2022/12/23/6.htm
23 Dec 2022
Severe COVID-19 associated with more IBS, less constipation
A prospective multicenter study found that patients hospitalized for COVID-19 had significantly higher rates of irritable bowel syndrome (IBS) and fewer problems with constipation at 12 months than controls.
https://gastroenterology.acponline.org/archives/2022/12/23/1.htm
23 Dec 2022
More tools available for treating IBS
Irritable bowel syndrome (IBS) is not a new disorder, but understanding of its pathophysiology and treatment has greatly progressed over the years.
https://gastroenterology.acponline.org/archives/2023/02/24/7.htm
24 Feb 2023